{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:09:00Z","timestamp":1790244540283,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05406-8","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:23:02Z","timestamp":1790241782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporary pharmacologically induced ejaculatory dysfunction influences surgical decision-making in sexually active men with benign prostatic hyperplasia: a prospective interventional study"],"prefix":"10.1007","author":[{"given":"Vincenzo","family":"Iossa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Buonopane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Crocetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Balsamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"Suppl 9","key":"5406_CR1","first-page":"S3","volume":"7","author":"CG Roehrborn","year":"2005","unstructured":"Roehrborn CG (2005) Benign prostatic hyperplasia: an overview. Rev Urol 7(Suppl 9):S3\u2013S14 (PMID: 16985902; PMCID: PMC1477638)","journal-title":"Rev Urol"},{"issue":"3","key":"5406_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132(3):474\u2013479. https:\/\/doi.org\/10.1016\/s0022-5347(17)49698-4","journal-title":"J Urol"},{"issue":"6","key":"5406_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099\u20131109. https:\/\/doi.org\/10.1016\/j.eururo.2014.12.038","journal-title":"Eur Urol"},{"issue":"2","key":"5406_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-committee of the International Continence Society (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167\u2013178. https:\/\/doi.org\/10.1002\/nau.10052","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"5406_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eururo.2026.03.020","volume":"90","author":"M Baboudjian","year":"2026","unstructured":"Baboudjian M, Creta M, Pyrgidis N, Moris L, Duran MB, de Nunzio C, Elterman D, Hashim H, Herrmann TRW, Karavitakis M, Malde S, Netsch C, Rieken M, Sakalis V, Tutolo M, Schouten N, Cornu JN (2026) Summary paper on the 2026 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol 90(1):44\u201359. https:\/\/doi.org\/10.1016\/j.eururo.2026.03.020","journal-title":"Eur Urol"},{"issue":"4","key":"5406_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JU.0000000000001298","volume":"204","author":"JK Parsons","year":"2020","unstructured":"Parsons JK, Dahm P, K\u00f6hler TS, Lerner LB, Wilt TJ (2020) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol 204(4):799\u2013804. https:\/\/doi.org\/10.1097\/JU.0000000000001298","journal-title":"J Urol"},{"issue":"25","key":"5406_CR7","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"JD McConnell","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349(25):2387\u20132398. https:\/\/doi.org\/10.1056\/NEJMoa030656","journal-title":"N Engl J Med"},{"issue":"3","key":"5406_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/nau.20481","volume":"27","author":"MM Barendrecht","year":"2008","unstructured":"Barendrecht MM, Abrams P, Schumacher H, de la Rosette JJ, Michel MC (2008) Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn 27(3):226\u2013230. https:\/\/doi.org\/10.1002\/nau.20481. (PMID: 17638312)","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"5406_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.urology.2004.07.031","volume":"64","author":"B Djavan","year":"2004","unstructured":"Djavan B, Chapple C, Milani S, Marberger M (2004) State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 64(6):1081\u20131088. https:\/\/doi.org\/10.1016\/j.urology.2004.07.031","journal-title":"Urology"},{"issue":"1","key":"5406_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/13645700601159410","volume":"16","author":"J Rassweiler","year":"2007","unstructured":"Rassweiler J, Schulze M, Stock C, Teber D, De La Rosette J (2007) Bipolar transurethral resection of the prostate--technical modifications and early clinical experience. Minim Invasive Ther Allied Technol 16(1):11\u201321. https:\/\/doi.org\/10.1080\/13645700601159410","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"1","key":"5406_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.juro.2008.03.058","volume":"180","author":"O Reich","year":"2008","unstructured":"Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG, Urology Section of the Bavarian Working Group for Quality Assurance (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180(1):246\u2013249. https:\/\/doi.org\/10.1016\/j.juro.2008.03.058","journal-title":"J Urol"},{"issue":"6","key":"5406_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","volume":"67","author":"JN Cornu","year":"2015","unstructured":"Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066\u20131096. https:\/\/doi.org\/10.1016\/j.eururo.2014.06.017","journal-title":"Eur Urol"},{"issue":"5","key":"5406_CR13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol 50(5):969\u2013979. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.042","journal-title":"Eur Urol"},{"issue":"5","key":"5406_CR14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG (2016) Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 195(5):1529\u20131538. https:\/\/doi.org\/10.1016\/j.juro.2015.10.181","journal-title":"J Urol"},{"key":"5406_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","volume":"126","author":"KT McVary","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG (2019) Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 126:171\u2013179. https:\/\/doi.org\/10.1016\/j.urology.2018.12.041","journal-title":"Urology"},{"key":"5406_CR16","doi-asserted-by":"publisher","unstructured":"Fakh IM, Rahardjo HE (2026). Sexual function and clinical outcomes following rez\u016bm therapy for benign prostatic hyperplasia: an updated systematic review including large prostate volumes. low urin tract symptoms. 18(4):e70081. https:\/\/doi.org\/10.1111\/luts.70081. PMID: 42480974; PMCID: PMC13387859.","DOI":"10.1111\/luts.70081"},{"issue":"1","key":"5406_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-026-06495-x","volume":"44","author":"L Cindolo","year":"2026","unstructured":"Cindolo L, Minore A, Schwartzmann I, Alejo AF, Imperatore V, Iossa V, Ebbing J, Destefanis P, Hindley R, Emara A, Pastore A, Sequi MB, Balsamo R, Knazik R, Coscarella M, De Nunzio C, Secco S (2026) Water vapor thermotherapy and high-grade Clavien-Dindo complications: retrospective analysis of 10 cases. World J Urol 44(1):392. https:\/\/doi.org\/10.1007\/s00345-026-06495-x","journal-title":"World J Urol"},{"issue":"5","key":"5406_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/iju.15410","volume":"31","author":"M Samir","year":"2024","unstructured":"Samir M, Elaal AAA, Gad KAS, Basyony MW (2024) Two-year follow-up comparing Rez\u016bm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic\u00a0hyperplasia. A prospective randomized study. Int J Urol 31(5):545\u2013550. https:\/\/doi.org\/10.1111\/iju.15410","journal-title":"Int J Urol"},{"issue":"3","key":"5406_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013251.pub2","volume":"3","author":"TW Kang","year":"2020","unstructured":"Kang TW, Jung JH, Hwang EC, Borofsky M, Kim MH, Dahm P (2020) Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst Rev 3(3):CD013251. https:\/\/doi.org\/10.1002\/14651858.CD013251.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"5406_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M (2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27(10):1361\u20131367. https:\/\/doi.org\/10.1007\/s11606-012-2077-6","journal-title":"J Gen Intern Med"},{"issue":"9","key":"5406_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1056\/NEJMp1109283","volume":"366","author":"MJ Barry","year":"2012","unstructured":"Barry MJ, Edgman-Levitan S (2012) Shared decision making\u2013pinnacle of patient-centered care. N Engl J Med 366(9):780\u2013781. https:\/\/doi.org\/10.1056\/NEJMp1109283. (PMID: 22375967)","journal-title":"N Engl J Med"},{"issue":"8","key":"5406_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/s0895-4356(98)00044-4","volume":"51","author":"SJ Frankel","year":"1998","unstructured":"Frankel SJ, Donovan JL, Peters TI, Abrams P, Dabhoiwala NF, Osawa D, Lin AT (1998) Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 51(8):677\u2013685. https:\/\/doi.org\/10.1016\/s0895-4356(98)00044-4","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"5406_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.urology.2008.05.034","volume":"73","author":"RC Rosen","year":"2009","unstructured":"Rosen RC, Wei JT, Althof SE, Seftel AD, Miner M, Perelman MA (2009) Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry. Urology 73(3):562\u2013566. https:\/\/doi.org\/10.1016\/j.urology.2008.05.034","journal-title":"Urology"},{"key":"5406_CR24","doi-asserted-by":"publisher","unstructured":"Corona G, Lee DM, Forti G, O\u2019Connor DB, Maggi M, O\u2019Neill TW, Pendleton N, Bartfai G, Boonen S, Casanueva FF, Finn JD, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC (2010) EMAS Study Group. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med. 7(4 Pt 1):1362\u201380. https:\/\/doi.org\/10.1111\/j.1743-6109.2009.01601.x. Epub 2009 19. PMID: 19929914.","DOI":"10.1111\/j.1743-6109.2009.01601.x"},{"issue":"Supp 1","key":"5406_CR25","first-page":"S14","volume":"11","author":"SA Kaplan","year":"2009","unstructured":"Kaplan SA (2009) Side Effects of alpha-blocker use: retrograde ejaculation. Rev Urol. Fall 11(Supp 1):S14\u2013S18 (PMID: 20126607; PMCID: PMC2812888)","journal-title":"Rev Urol. Fall"},{"issue":"3","key":"5406_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.ju.0000097026.43866.cc","volume":"171","author":"CG Roehrborn","year":"2004","unstructured":"Roehrborn CG, Schwinn DA (2004) Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 171(3):1029\u20131035. https:\/\/doi.org\/10.1097\/01.ju.0000097026.43866.cc. (PMID: 14767264)","journal-title":"J Urol"},{"issue":"7","key":"5406_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1464-410X.2009.08503.x","volume":"104","author":"RC Rosen","year":"2009","unstructured":"Rosen RC, Fitzpatrick JM, ALF-LIFE Study Group (2009) Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. BJU Int 104(7):974\u2013983. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08503.x","journal-title":"BJU Int"},{"issue":"6","key":"5406_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/s0090-4295(98)00126-5","volume":"51","author":"H Lepor","year":"1998","unstructured":"Lepor H, Tamsulosin Investigator Group (1998) Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Urology 51(6):892\u2013900. https:\/\/doi.org\/10.1016\/s0090-4295(98)00126-5","journal-title":"Urology"},{"issue":"1","key":"5406_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000019919","volume":"36","author":"B Djavan","year":"1999","unstructured":"Djavan B, Marberger M (1999) A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 36(1):1\u201313. https:\/\/doi.org\/10.1159\/000019919. (PMID: 10364649)","journal-title":"Eur Urol"},{"issue":"2","key":"5406_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4081\/aiua.2022.2.252","volume":"94","author":"R Bapir","year":"2022","unstructured":"Bapir R, Bhatti KH, Eliwa A, Garc\u00eda-Perdomo HA, Gherabi N, Hennessey D, Magri V, Mourmouris P, Ouattara A, Perletti G, Philipraj J, Trinchieri A, Buchholz N (2022) Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis. Arch Ital Urol Androl 94(2):252\u2013263. https:\/\/doi.org\/10.4081\/aiua.2022.2.252","journal-title":"Arch Ital Urol Androl"},{"issue":"6","key":"5406_CR31","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/jsm.12525","volume":"11","author":"M Gacci","year":"2014","unstructured":"Gacci M, Ficarra V, Sebastianelli A, Corona G, Serni S, Shariat SF, Maggi M, Zattoni F, Carini M, Novara G (2014) Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. J Sex Med 11(6):1554\u20131566. https:\/\/doi.org\/10.1111\/jsm.12525","journal-title":"J Sex Med"},{"issue":"4","key":"5406_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","volume":"173","author":"JT Wei","year":"2005","unstructured":"Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173(4):1256\u20131261. https:\/\/doi.org\/10.1097\/01.ju.0000155709.37840.fe","journal-title":"J Urol"},{"issue":"7","key":"5406_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1464-410X.2004.04765.x","volume":"93","author":"MJ Speakman","year":"2004","unstructured":"Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R, British Association of Urological Surgeons (2004) Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 93(7):985\u2013990. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.04765.x","journal-title":"BJU Int"},{"issue":"1","key":"5406_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4081\/aiua.2015.1.8","volume":"87","author":"C Pavone","year":"2015","unstructured":"Pavone C, Abbadessa D, Scaduto G, Caruana G, Scalici Gesolfo C, Fontana D, Vaccarella L (2015) Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients. Arch Ital Urol Androl 87(1):8\u201313. https:\/\/doi.org\/10.4081\/aiua.2015.1.8","journal-title":"Arch Ital Urol Androl"},{"issue":"1","key":"5406_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0022-5347(05)65370-0","volume":"141","author":"WK Mebust","year":"1989","unstructured":"Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141(1):243\u2013247. https:\/\/doi.org\/10.1016\/s0022-5347(05)65370-0","journal-title":"J Urol"},{"issue":"3","key":"5406_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eururo.2010.06.005","volume":"58","author":"SA Ahyai","year":"2010","unstructured":"Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384\u2013397. https:\/\/doi.org\/10.1016\/j.eururo.2010.06.005","journal-title":"Eur Urol"},{"issue":"5","key":"5406_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/bju.13714","volume":"119","author":"C Gratzke","year":"2017","unstructured":"Gratzke C, Barber N, Speakman MJ, Berges R, Wetterauer U, Greene D, Sievert KD, Chapple CR, Patterson JM, Fahrenkrug L, Schoenthaler M, Sonksen J (2017) Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int 119(5):767\u2013775. https:\/\/doi.org\/10.1111\/bju.13714","journal-title":"BJU Int"},{"issue":"11","key":"5406_CR38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.96677","volume":"17","author":"ME Rahman","year":"2025","unstructured":"Rahman ME, Haque F, Hasan MR, Hassan M, Tamanna R (2025) A narrative review of robotic aquablation in benign prostatic hyperplasia care: where we are now. Cureus 17(11):e96677. https:\/\/doi.org\/10.7759\/cureus.96677","journal-title":"Cureus"},{"issue":"5","key":"5406_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40258-015-0218-x","volume":"14","author":"A Ray","year":"2016","unstructured":"Ray A, Morgan H, Wilkes A, Carter K, Carolan-Rees G (2016) The urolift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a NICE Medical Technology Guidance. Appl Health Econ Health Policy 14(5):515\u2013526. https:\/\/doi.org\/10.1007\/s40258-015-0218-x","journal-title":"Appl Health Econ Health Policy"},{"key":"5406_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","volume":"153","author":"B Chughtai","year":"2021","unstructured":"Chughtai B, Elterman D, Shore N, Gittleman M, Motola J, Pike S, Hermann C, Terrens W, Kohan A, Gonzalez RR, Katz A, Schiff J, Goldfischer E, Grunberger I, Tu LM, Alshak MN, Kaminetzky J (2021) The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology 153:270\u2013276. https:\/\/doi.org\/10.1016\/j.urology.2020.12.022","journal-title":"Urology"},{"issue":"2","key":"5406_CR41","doi-asserted-by":"publisher","first-page":"e20250423","DOI":"10.1590\/s1677-5538.ibju.2025.0423","volume":"52","author":"IZ Pires","year":"2026","unstructured":"Pires IZ, Gobbo MODS, Fujimura AY Jr, Milbradt TL, Sudo RYU, Pereira M, Filho MN, Carvalhal GF, Averbeck MA (2026) Transperineal laser ablation for treatment of lower urinary tract symptoms in benign prostate enlargement: a systematic review and meta-analysis. Int Braz J Urol. 52(2):e20250423 (PMID: 41576182; PMCID: PMC13124165)","journal-title":"Int Braz J Urol."},{"issue":"4","key":"5406_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.23736\/S2724-6051.25.06374-8","volume":"77","author":"B Akgul","year":"2025","unstructured":"Akgul B, Aydin A, Cakir OO, Tozsin A, Noel O, Balasar M, Aktoz T, Tunc L, Fiori C, Rassweiler J, Guven S, Ahmed K (2025) Impact of minimally invasive surgical therapies on sexual function in benign prostatic hyperplasia: a systematic review. Minerva Urol Nephrol 77(4):459\u2013471. https:\/\/doi.org\/10.23736\/S2724-6051.25.06374-8","journal-title":"Minerva Urol Nephrol"},{"issue":"3","key":"5406_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG (2021) Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 206(3):715\u2013724. https:\/\/doi.org\/10.1097\/JU.0000000000001778","journal-title":"J Urol"},{"issue":"9","key":"5406_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/RRU.S143679.PMID:28861405;PMCID:PMC5572953","volume":"21","author":"MF Darson","year":"2017","unstructured":"Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, Delgado-Rodriguez C, Gonzalez RR (2017) Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rez\u016bm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol 21(9):159\u2013168. https:\/\/doi.org\/10.2147\/RRU.S143679.PMID:28861405;PMCID:PMC5572953","journal-title":"Res Rep Urol"},{"issue":"4 Pt 1","key":"5406_CR45","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2006.06.004","volume":"176","author":"WJ Hellstrom","year":"2006","unstructured":"Hellstrom WJ, Sikka SC (2006) Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 176(4 Pt 1):1529\u20131533. https:\/\/doi.org\/10.1016\/j.juro.2006.06.004","journal-title":"J Urol"},{"issue":"3","key":"5406_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00003495-200666030-00002","volume":"66","author":"MM van Dijk","year":"2006","unstructured":"van Dijk MM, de la Rosette JJ, Michel MC (2006) Effects of alpha(1)-adrenoceptor antagonists on male sexual function. Drugs 66(3):287\u2013301. https:\/\/doi.org\/10.2165\/00003495-200666030-00002. (PMID: 16526818)","journal-title":"Drugs"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05406-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05406-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05406-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:23:03Z","timestamp":1790241783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05406-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":46,"alternative-id":["5406"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05406-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"1 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all subjects to use their data and information for publication.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}